TherapeuticsMD share price logo

TherapeuticsMD

NASDAQ: TXMD

$2.18

(+0.03%)

Live

as on

TherapeuticsMD Stock Performance

as on September 19, 2026 at 5:03 am IST

  • Day's High

    $2.18
    $2.19

    0.46%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.99
    $2.95
    downward going graph

    54.59%

    Downside

    35.32%

    Upside

    downward going graph

TherapeuticsMD share price movements today

Previous Close
$2.18
Open
$2.19
Volume
19.3K
Market Cap
$25.2M
Day's Low - High
$2.18 - $2.19
52 Week Low - High
$0.99 - $2.95

TherapeuticsMD Historical Returns

1 Month Return
+ 8.46 %
3 Month Return
+ 11.79 %
1 Year Return
+ 101.85 %
3 Year Return
-36.26 %
5 Year Return
-93.73 %

TherapeuticsMD Stock Fundamentals & Key Indicators

Check TherapeuticsMD market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$25.2M

EPS (TTM)

-0.0188

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.81%

PE Ratio (TTM)

-115.96

Industry PE ratio

1.40

PEG Ratio

-0.10859276223781832

EBITDA

-4.2M

Revenue (TTM)

3.3M

Profit Margin

89.94%

Return On Equity TTM

-0.80%

TherapeuticsMD Stock Valuation

Track how TherapeuticsMD P/E has moved over time to understand its valuation trends.

TherapeuticsMD in the last 5 years

  • Overview

  • Trends

Lowest (-33.13x)

December 31, 2025

Today (-33.13x)

December 31, 2025

Industry (1.40x)

December 31, 2025

Highest (0.45x)

March 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -33.13x

TherapeuticsMD vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of TherapeuticsMD with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
SELL$25.2M-93.73%-115.9689.94%0.00%
BUY$21.3B148.54%16.5586.14%0.00%
HOLD$19.1B26.23%-47.5834.83%2.82%
BUY$40.0BNA18.7765.57%1.35%
BUY$30.3B-63.21%12.0170.87%2.86%

Stock Returns calculator for TherapeuticsMD Stock including INR - Dollar returns

The TherapeuticsMD stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

TherapeuticsMD investment value today

Current value as on today

₹2,19,396

Returns

₹1,19,396

(+119.4%)

Returns from TherapeuticsMD Stock

₹1,01,852 (+101.85%)

Dollar Impact

₹17,544 (+17.54%)

Analyst Recommendation on TherapeuticsMD Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for TherapeuticsMD. Average target price of $5

TherapeuticsMD Share Price Target

Get share price movements and forecasts by analysts on TherapeuticsMD.

What analysts predicted

56.4%UPSIDE

Target Price

$5

Current Price

$2.18

Analyzed by

6 Analysts

Target

$5.00

TherapeuticsMD target price $5, a slight upside of 56.4% compared to current price of $2.18. According to 6 analysts rating.

Indian Investors' Interest in TherapeuticsMD Stock

Search interest for TherapeuticsMD Stock has increased by 25% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:25% versus previous 30 day period

TherapeuticsMD Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-1
-2
-1
0
-1
0
0
-1
0
0
EBITDA
0
0
0
0
-1
0
0
-3
0
0
Interest Expense
-
0
0
-
0
0
0
0
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
0
-1
0
0
0
0
0
0
0
0
Income Tax Expense
-
-
-
0
0
-
-
0
-
-
Net Income
0
-1
0
0
0
0
0
0
0
0
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
62.14%

TherapeuticsMD Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Total Revenue
16
16
49
64
2
69
1
1
3
Gross Profit
14
13
43
48
1
68
1
1
3
Operating Income
-77
-130
-151
-155
-79
10
-8
-4
-4
EBITDA
-76
-127
-158
-153
-78
11
-7
-3
-3
Interest Expense
-
4
17
28
32
-
0
-
0
Depreciation
0
0
1
4
0
1
0
1
1
Income Before Tax
-76
-132
-176
-183
-79
1
-7
-2
0
Income Tax Expense
-
-
-
-
-
-
0
0
-
Net Income
-76
-132
-176
-183
-172
111
-10
-2
0
Net Profit Margin
84.28%
83.00%
87.24%
75.37%
45.51%
98.00%
100.00%
100.00%
100.00%

TherapeuticsMD Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
0
-1
0
0
0
0
0
0
0
0
Operating Cash Flow
0
0
0
0
0
0
1
0
0
0
Investing Cash Flow
-
-
-
-
-
-
-
-
-
-
Financing Cash Flow
-
-
-
-
-
-
-
-
-
-
Change in Cash
0
0
0
0
0
0
1
0
0
0

TherapeuticsMD Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Net Income
-76
-132
-176
-183
-79
1
-7
-2
0
Operating Cash Flow
-76
-106
-165
-159
-147
-4
-48
0
2
Investing Cash Flow
0
-21
-23
-1
-2
223
-
-
-
Financing Cash Flow
72
162
188
80
134
-235
3
-
-
Change in Cash
-4
34
0
-80
-15
-15
-44
0
2

Mutual Funds that own TherapeuticsMD Stock

Check out the Mutual Funds with significant holdings in TherapeuticsMD.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.055866%
353697
Fidelity Concord Street Trust
0.841299%
97375
Bridgeway Funds, Inc.
0.146876%
17000
Gabelli Investor Funds Inc
0.031103%
3600
DFA INVESTMENT DIMENSIONS GROUP INC
0.012795%
1481

Global Institutional Holdings in TherapeuticsMD

Funds
Holdings
Vanguard
3.06%
Bridgeway
0.15%
Dimensional
0.1%

Insights on TherapeuticsMD

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, TXMD has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, TXMD stock has moved up by 101.9%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 724.0K → 869.0K (in $), with an average increase of 16.7% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -619.0K → 155.0K (in $), with an average increase of 395.1% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation Common Stock has given 74.4% return, outperforming this stock by 110.7%

About TherapeuticsMD

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
OrganisationTherapeuticsMD
Headquarters951 Yamato Road, Boca Raton, FL, United States, 33431
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Marlan D. Walker J.D.
E-voting on sharesClick here to vote

Key Management of TherapeuticsMD

Name

Title

Mr. Marlan D. Walker J.D.

Chief Executive Officer

Mr. Joseph A. Ziegler

Principal Financial & Accounting Officer

FAQs

What is TherapeuticsMD share price today?

TherapeuticsMD share price today is $2.18 as on . TherapeuticsMD share today touched a day high of $2.19 and a low of $2.18.

What is the 52 week high and 52 week low for TherapeuticsMD share?

TherapeuticsMD share touched a 52 week high of $2.95 on and a 52 week low of $0.99 on . TherapeuticsMD stock price today i.e. is trending at $2.18,which is 26.10% down from its 52 week high and 120.20% up from its 52 week low.

What is TherapeuticsMD's market capitalisation today?

TherapeuticsMD market capitalisation is $0.00T as on .

How to invest in TherapeuticsMD Stock (TXMD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for TherapeuticsMD on INDmoney app. Click on Buy button. You can invest as low as $1.5 in TherapeuticsMD Shares that will get you 0.6881 shares as per TherapeuticsMD share price of $2.18 per share as on September 18, 2026 at 11:33 pm IST.

What is the minimum amount required to buy TherapeuticsMD Stock (TXMD) from India?

Indian investors can start investing in TherapeuticsMD (TXMD) shares with as little as ₹95.8725 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.73 in TherapeuticsMD stock (as per the Rupee-Dollar exchange rate as on ). Based on TherapeuticsMD share’s latest price of $2.18 as on September 18, 2026 at 11:33 pm IST, you will get 4.5872 shares of TherapeuticsMD. Learn more about fractional shares .

What are the returns that TherapeuticsMD has given to Indian investors in the last 5 years?

TherapeuticsMD stock has given -93.73% share price returns and 30.29% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?